[1]
“THE STATUS OF ADHERENCE IN LAMIVUDIN, TENOFOVIR AND DOLUTEGRAVIR USAGE TO TREAT HIV PATIENTS”, YHCĐ, vol. 63, no. Số tiếng Anh, Dec. 2022, doi: 10.52163/yhc.v63i9.557.